Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 180,133 | 232,123 | 366,846 | 412,178 | 340,351 |
| Receivables | 260,881 | 239,590 | 237,454 | 214,448 | 324,451 |
| Inventories | 175,230 | 167,554 | 148,079 | 133,563 | 125,582 |
| TOTAL | $631,141 | $700,586 | $776,718 | $782,374 | $822,073 |
| Non-Current Assets | |||||
| PPE Net | 233,372 | 227,588 | 223,475 | 219,400 | 214,156 |
| Intangibles | 827,795 | 1,099,607 | 790,173 | 805,134 | 812,186 |
| Other Non-Current Assets | 130,710 | 91,875 | 59,570 | 79,391 | 74,072 |
| TOTAL | $1,191,877 | $1,419,070 | $1,073,218 | $1,103,925 | $1,100,414 |
| Total Assets | $1,823,018 | $2,119,656 | $1,849,936 | $1,886,299 | $1,922,487 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 17,719 | 17,708 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 58,952 | 61,885 | 50,518 | 50,724 | 56,325 |
| Accrued Expenses | 244,653 | 254,940 | 215,430 | 251,821 | 270,436 |
| TOTAL | $321,324 | $334,533 | $265,948 | $302,545 | $326,761 |
| Non-Current Liabilities | |||||
| Long Term Debt | 813,545 | 812,375 | 435,265 | 429,878 | 424,595 |
| Other Non-Current Liabilities | 64,175 | 68,888 | 37,161 | 36,986 | 35,952 |
| TOTAL | $877,720 | $881,263 | $510,598 | $514,328 | $533,317 |
| Total Liabilities | $1,199,044 | $1,215,796 | $776,546 | $816,873 | $860,078 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,748 | 73,879 | 73,859 | 73,814 | 72,603 |
| Common Shares | 739 | 742 | 741 | 733 | 729 |
| Retained earnings | 98,192 | 377,777 | 557,114 | 559,815 | 570,223 |
| Other shareholders' equity | -8,013 | -3,960 | -7,647 | -7,577 | -10,620 |
| TOTAL | $623,974 | $903,860 | $1,073,390 | $1,069,426 | $1,062,409 |
| Total Liabilities And Equity | $1,823,018 | $2,119,656 | $1,849,936 | $1,886,299 | $1,922,487 |